Search - tctmd.com

Displaying 81 - 100 of 183

Sort: Relevancy | Date

Presentation TVT 2022

Bringing Physiology to the Bedside: Evaluating Right Ventricular and Left Ventricular Function and Right Ventricular-Pulmonary Arterial Coupling in the Patient With Significant Tricuspid Regurgitation

Presenter: Philipp Lurz

June 10, 2022

Presentation TVT 2022

A Concise Review of Right Atrial, Right Ventricular, and Pulmonary Arterial Properties in the Setting of Tricuspid Regurgitation

Presenter: Michael Brener

June 10, 2022

Presentation TVT 2022

TAVR Unload

Presenter: Nicolas Van Mieghem

June 10, 2022

Presentation TVT 2022

Exercise PVR, A Key Predictor of Benefit of Atrial Shunt Therapy in HFpEF?

Presenter: Sanjiv Shah

June 10, 2022

RELIEVE HF: Different Patient Selection and Study Design – Should We Expect Different Results?

Presentation TVT 2022

Less Invasive Ventricular Enhancement for HFrEF

Presenter: John Boehmer

June 10, 2022

Presentation TVT 2022

Post-TAVR Heart Failure: Mechanism, Incidence, Risk Factors, and Treatment

Presenter: Chetan Huded

June 10, 2022

Presentation TVT 2022

What (Else) Have We Learned From REDUCE-LAP II?

Presenter: Sanjiv Shah

June 10, 2022

Presentation TVT 2022

Overview of the Interatrial Shunt Device Landscape: Conceptual Basis and Devices

Presenter: Daniel Burkhoff

June 10, 2022

Presentation TVT 2022

Myocardial Intramural Remodeling by Transvenous Interstitial teTHer

Presenter: Christopher Bruce

June 10, 2022

Presentation TVT 2022

The Carillon Mitral Contour System for Treating HF With MR

Presenter: Randall Starling

June 10, 2022

Presentation TVT 2022

The Accucinch Ventricular Restoration System for HFrEF

Presenter: Ulrich Jorde

June 10, 2022

Presentation TVT 2022

Rationale for Physical Reverse LV Remodeling as a Therapy for HFrEF

Presenter: Daniel Burkhoff

June 10, 2022

Presentation TVT 2022

A CLINICAL TEASER: Indications and Clinical Outcomes of TEER in Acute Decompensated Heart Failure

Presenter: Gilbert Tang

June 10, 2022

Presentation TVT 2022

The Alleviant No-Implant Interatrial Shunt for HF: The ALLEVIATE HF1 Trial Results

Presenter: Peter S. Fail

June 10, 2022

Presentation TVT 2022

Right-Ventricular Failure

Presenter: Robert L. Smith

June 09, 2022

Presentation TVT 2022

V-in-R: Post-Interventional Management of PVL

Presenter: Mackram F. Eleid

June 09, 2022

Presentation TVT 2022

V-in-V: Bioprosthetic Mitral Valve Fracture and Remodeling

Presenter: Adnan K. Chhatriwalla

June 09, 2022

Presentation TVT 2022

Bioprosthetic Mitral Valve Failure: Transcatheter Options and Outcomes

Presenter: Danny Dvir

June 09, 2022

Presentation TVT 2022

Bioprosthetic Mitral Valve Failure: When Is Redo-Surgery the Best Option?

Presenter: Steven Bolling

June 09, 2022

Presentation TVT 2022

Design and Rationale of the CORCINCH-HF Pivotal Study

Presenter: Ulrich Jorde

June 09, 2022

Advertisement

Bringing Physiology to the Bedside: Evaluating Right Ventricular and Left Ventricular Function and Right Ventricular-Pulmonary Arterial Coupling in the Patient With Significant Tricuspid Regurgitation

A Concise Review of Right Atrial, Right Ventricular, and Pulmonary Arterial Properties in the Setting of Tricuspid Regurgitation

TAVR Unload

Exercise PVR, A Key Predictor of Benefit of Atrial Shunt Therapy in HFpEF?

Less Invasive Ventricular Enhancement for HFrEF

Post-TAVR Heart Failure: Mechanism, Incidence, Risk Factors, and Treatment

What (Else) Have We Learned From REDUCE-LAP II?

Overview of the Interatrial Shunt Device Landscape: Conceptual Basis and Devices

Myocardial Intramural Remodeling by Transvenous Interstitial teTHer

The Carillon Mitral Contour System for Treating HF With MR

The Accucinch Ventricular Restoration System for HFrEF

Rationale for Physical Reverse LV Remodeling as a Therapy for HFrEF

A CLINICAL TEASER: Indications and Clinical Outcomes of TEER in Acute Decompensated Heart Failure

The Alleviant No-Implant Interatrial Shunt for HF: The ALLEVIATE HF1 Trial Results

Right-Ventricular Failure

V-in-R: Post-Interventional Management of PVL

V-in-V: Bioprosthetic Mitral Valve Fracture and Remodeling

Bioprosthetic Mitral Valve Failure: Transcatheter Options and Outcomes

Bioprosthetic Mitral Valve Failure: When Is Redo-Surgery the Best Option?

Design and Rationale of the CORCINCH-HF Pivotal Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content